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Gr1+ ‘‘inflammatory’’ monocytes are emerging as key players in the innate immune response to infection and
vaccination. In a recent issue of Immunity, Dunay et al. (2008) report a surprisingly crucial role for inflamma-
tory monocytes in mucosal resistance to the parasitic agent Toxoplasma gondii.Despite our long and widely held belief
that cells of the mononuclear phagocyte
system play important functions in in-
flammation, antimicrobial defense, and
tissue homeostasis, only recently have
advances been made into defining sub-
sets of the circulating monocyte pool and
in clearly delineating their physiological
roles. In 2003, Geissman and colleagues
(Geissman et al., 2003) identified two
functional subsets of mouse blood mono-
cytes based on differential expression of
the chemokine receptors CX3CR1 (the re-
ceptor for the tissue chemokine known




also expressed the surface marker Ly6
C/G (generally known as Gr1) and was
shown to represent short-lived inflam-
matory monocytes. A second CX3CR1
hi
CCR2 Gr1 subset preferentially homes
to noninflamed organs and gives rise to
long-lived tissue macrophages. Analo-
gous subsets also exist in humans. The
dominant monocyte pool corresponds to
the Gr1 subset in the mouse, expressing
high levels of the lipopolysaccharide
coreceptor, CD14, and low levels of the
Fc receptor component, FcgRIII (CD16).
In humans, the CD14loCD16hi monocyte
corresponds with the Gr1+ inflammatory
monocyte in the mouse (reviewed in Ran-
dolph et al., 2008). These two monocyte
subsets do not represent separate line-
ages, as the Gr1+ subset can give rise
to the Gr1 monocytes homeostatically.
Under inflammatory conditions, however,
Gr1+ monocytes have been shown to dif-
ferentiate into dendritic cells (DCs) and
have been implicated in the priming of
naive T cells. In addition to participating
in the generation of adaptive immune192 Cell Host & Microbe 4, September 11, 2responses, monocyte-derived cells also
serve innate antimicrobial effector cells.
In Listeria monocytogenes-infected mice,
CCR2+ inflammatory monocytes are re-
cruited to the spleen and acquire DC
markers and express the potent anti-
microbial effector molecules, TNF-a and
iNOS (Serbina et al., 2003). Because these
inflammatory monocyte-derived TNF-a-
and iNOS-producing DCs (Tip DCs) them-
selves do not harbor bacteria, they were
proposed to be the major innate effector
cell mediating defense against infections
acquired or spread through the blood-
stream.
In a recent issue of Immunity, Dunay
et al. (2008) report that inflammatory
Gr1+ monocytes play an essential role in
mucosal host defense in the small intes-
tine following oral infection with the pro-
tozoan parasite Toxoplasma gondii, the
causative agent of toxoplasmosis in hu-
mans and animals. Following invasion of
the intestinal epithelium by Toxoplasma
parasites,Gr1+monocytes (expressing the
macrophage markers F4/80 and CD11b
but lacking the dendritic cell marker
CD11c) were rapidly recruited and estab-
lished a defensive perimeter within the
villi of the ileum. In mice with defective
Gr1+ monocyte pools (CCR2 and MCP-1
knockouts), the paucity of inflammatory
monocytes recruited to the intestine re-
sulted in unbridled replication of the para-
site, tissue necrosis, neutrophilic inflam-
mation, and ultimately acute mortality.
Importantly, adoptive transfer of sorted
Gr1+ but not Gr1 cells was sufficient to
rescue the susceptibility of CCR2/
mice. Given the great diversity and abun-
dance of innate lymphoid and myeloid
cells that normally reside in the intestinal
mucosa that could respond to the para-008 ª2008 Elsevier Inc.site, the requirement for newly recruited
inflammatory monocytes in the control
of T. gondii replication in the gut is some-
what surprising. In fact, myeloid dendritic
cells expressing the chemokine receptor
CCR6 and previously implicated in innate
immune recognition of orally acquired
Salmonella infection were not essential
for resistance to T. gondii (Dunay et al.,
2008). An earlier study (Jung et al., 2000)
also showed that the absence of resident
macrophages (in CX3CR1 knockouts) did
not result in susceptibility to oral toxo-
plasmosis. In CCR2 andMCP-1 knockout
mice, macrophage and DC cell numbers
increased normally, but these cells were
apparently ineffective in controlling infec-
tion when inflammatory monocytes were
absent.
What then are the unique properties
and functions that make the recruited
monocytes so very indispensable for mu-
cosal defense? Cell-autonomous activa-
tion of hemopoietic and nonhemopoietic
elements by interferon-g (IFN-g) is abso-
lutely critical for control of intracellular
parasite replication and dissemination.
Previous studies (including Ling et al.,
2006) have shown that inflammatory
monocytes similarly recruited into the
peritoneal cavity following T. gondii infec-
tion express the IFN-g-inducible antimi-
crobial enzymes iNOS and IGTP, which
mediate inhibition of parasite replication
and effect the destruction of the parasite’s
intracellularvacuolarniche (Figure1,arrow
#1). Although the antimicrobial potency
of inflammatory monocytes recruited to
the lamina propia was not assessed di-
rectly in this study (Dunay et al., 2008),
the lamina propria-localized Gr1+ cells
expressed TNF-a and iNOS and, thus,
could directly mediate anti-Toxoplasma
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PreviewsFigure 1. Proposed Roles for Inflammatory Monocyte-Derived Cells in Infection and Immunity to T. gondii
Invasion of the intestinal mucosa by T. gondii acquired orally induces recruitment of circulating Gr1+ inflammatory monocytes into the lamina propria of the small
intestine (1) where theymight exert direct antimicrobial effects through production of nitric oxide (via iNOS induction) and TNF-a. Upon encountering the parasites
in the intestinal submucosa, somemonocyte-derived cells may travel through the lymphatics (2) to draining lymph nodes and differentiate into DCs. In the draining
lymph node, these DCs could help drive the optimal differentiation of T helper 1 (Th1) cells via interleukin 12 (IL-12) production and presentation of parasite-
derived epitopes. Finally, some infected monocytes may travel through the blood (3) and become recruited into the brain to establish chronic infection in the
form of tissue cysts.activities in the gut, analogous to the
protective function ascribed to Tip DCs
in Listeria-infected splenic tissue. The fail-
ure of CCR2/ and MCP-1/ mice to
restrain pathogen growth in the intestine
raises the question of why epithelial cells
and resident and residual macrophages
and DCs recruited during infection were
not themselves armed by IFN-g to resist
infection. One interesting possibility is
that these cells may be less responsive
to activation by IFN-g and may require
additional immunostimulatory (e.g., TNF-a)
or antimicrobial (e.g., nitric oxide [NO])
factors provided in trans by the recruited
monocytes. Another explanation is that
lymphocyte activation and effector cyto-
kine production may have been impaired
in CCR2/ hosts, thus pinpointing the
critical underlying defect to be ‘‘up-
stream’’ of parasite restriction per se.
CCR2+ monocyte-derived DCs have
been shown to enhance Th1 (T helper 1)
differentiation and protective responses
during infection with Mycobacteriumtuberculosis and Leishmania major (re-
viewed in Geissman et al., 2008). The
study by Dunay et al. (2008) addressed
the issue of Th1 priming only tangentially
by demonstrating normal or slightly higher
levels of interleukin 12 (IL-12) and IFN-g in
the circulation of CCR2/ and MCP/
mice. This result could mean that Th1
priming was spared in these mice. In light
of the heightened tissue parasite bur-
dens, an equally likely scenario is that in-
nate production of IFN-g by natural killer
(NK) cells may have compensated for a
putative deficit in T cell-derived IFN-g.
During L. major infection, inflammatory
monocytes were recruited to the dermis
and differentiated locally into DCs, which
subsequently migrated into the draining
lymph node (LN) to drive the requisite Th1
response (Leon et al., 2007). Dunay et al.
(2008) find that inflammatory monocytes
in the lamina propria synthesize IL-12 and
yet do not express CD11c. As suggested
in the study, T. gondii infection may result
in blockade of monocytic differentiationCell Host & Microbe 4, Sinto DCs. Alternatively, it may well be that
only a small minority of the inflammatory
monocytes subsequently traffic to the
mesenteric lymph nodes (MLN) where
they could differentiate into DCs and pres-
ent antigens or otherwise ‘‘transfer’’ their
antigenic cargo to LN-resident DCs (see
Figure 1, arrow 2). Detailed analysis of the
local Th1 responses in the MLN as well
as in the lamina propia of CCR2/ and
monocyte-reconstituted CCR2/ mice
should clarify this issue. Further studies
tracking the fate of monocyte-derived
cells leaving the site of T. gondii infection
will likely yield more definitive insights.
The report by Dunay et al. will certainly
further interest and spur more investiga-
tions into the role of inflammatory mono-
cytes in mucosal responses occurring
in the lung, skin, and the gastrointestinal
and urogenital tracts. Because CCR2+
monocytes represent a readily mobilized
pool of ‘‘emergency’’ bi-potential (macro-
phage or DC) precursors, they are likely in-
volved in a range of immune responses,eptember 11, 2008 ª2008 Elsevier Inc. 193
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Previewsfrom acute infectious episodes to chronic
inflammatory diseases. The plasticity in
their phenotypic fates allows for shaping
of their functional repertoire by the specific
nature of the pathogenic stimulus present.
As the principal site of CCR2 control of the
inflammatorymonocyte pool is at the point
of their release from the bone marrow
(Dunay et al., 2008), the key question of
what alternative chemokine signals are
evoked by pathogens to recruit and mobi-
lize inflammatory monocytes remains. A
recent study demonstrated that systemic
induction of IFN-g during Listeria infection
remotely induced the expression of the
chemokines CXCL9 and CXCL10 (Drevets
et al., 2008), which presumably resulted in
CCR2-independent recruitment of mono-
cytes into the brain even before bacterial
colonization of the central nervous system
(CNS) occurred. Thus, Toxoplasma and
other neuroinvasive pathogens could be
subverting the innate cytokine response
by using inflammatory monocytes to ferryCoinfection Alters
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The antiherpes drug acyclovir was fo
providing a hypothesis to explain th
HIV disease progression. This report
copathogens.
HIV infection has been shown to worsen
the course of infection by many patho-
genic microbes and may lead to clinical
illness from infection by relatively non-
pathogenic or commensal organisms
(reviewed in USPHS/IDSA Prevention of
Opportunistic Infections Working Group,
1997; Sulkowski et al., 2000). While
many of these interactions appear to be
due to immune suppression, some infec-
tions are worsened in people with pre-
194 Cell Host & Microbe 4, September 11, 20themselves around and gain entry into the
brain to establish latent infection (Courret
et al., 2006; seeFigure 1, arrow#3). Inflam-
matory monocytes also likely differentiate
into perivascularmicroglial cells andmedi-
ate iNOS-dependent control of parasite
replication in the brain (Benevides et al.,
2008). By inducing robust Th1 and inflam-
matory monocytic responses, pathogens
could simultaneously increase the proba-
bility that their host organisms survive
acute infection, enhance their owndissem-
ination, and provide themselves a stable
chronic niche. Alas, the parasite seems to
always get the last laugh.
REFERENCES
Benevides, L., Milanezi, C., Yamauchi, L., Benja-
min, C., Silva, J., and Silva, N. (2008). Am. J.
Pathol. Published online August 18, 2008. 10.
2353/ajpath.2008.080129.
Courret, N., Darche, S., Sonigo, P., Milon, G., Bu-
zoni-Gatel, D., and Tardieux, I. (2006). Blood 107,
309–316.the Playing Field:
uce Acyclovir to In
r, Jr.2
ity of Iowa and Iowa City VA Medical Center, S
55, USA
und to inhibit HIV following its phosp
e observed beneficial effects of acy
underscores the importance of stud
served CD4 counts, suggesting a direct
effect of HIV on the coinfecting microbe.
The opposite effect has also been ob-
served both in vivo and in vitro: Infection
by a number of organisms is associated
with inhibition of HIV replication and de-
layed HIV disease progression, which
may be mediated by direct or indirect
interactions (Stapleton et al., 2004). For
example, HIV-induced depletion of CD4+
T lymphocytes is thought to be driven by
08 ª2008 Elsevier Inc.Drevets, D., Schawang, J., Dillon, M., Lerner, M.,
Bronze, M., and Brackett, D. (2008). J. Immunol.
181, 529–536.
Dunay, I.R., DaMatta, R., Fux, B., Presti, R., Greco,
S., Collona, M., and Sibley, L.D. (2008). Immunity
29, 306–317.
Geissman, F., Jung, S., and Littman, D. (2003).
Immunity 19, 71–82.
Geissman, F., Auffrey, C., Palframan, R., Wirrig, C.,
Ciocca, A., Campisis, L., Narni-Manichelli, E., and
Lauvau, G. (2008). Immunol. Cell Biol. 10.1038/
icb.2008.19.
Jung, S., Graemmel, P., Sunshine, M., Kreutzberg,
G., Sher, A., and Littman, D. (2000). Mol. Cell. Biol.
20, 4106–4114.
Leon, B., Lopez-Bravo, M., and Ardavin, C. (2007).
Immunity 26, 519–531.
Ling, Y., Shaw, M., Ayala, C., Coppens, I., Taylor,
G.A., Ferguson, D., and Yap, G.S. (2006). J. Exp.
Med. 203, 2063–2071.
Randolph, G., Jakubzick, C., and Qu, C. (2008).
Curr. Opin. Immunol. 20, 52–60.
Serbina, N., Salazar-Mather, T.P., Biron, C.A.,
Kuziel, W.A., and Pamer, E. (2003). Immunity 19,
59–70.hibit HIV
W54, GH, 200 Hawkins Drive,
horylation by human herpesviruses,
clovir therapy on HIV viral load and
ying HIV in the context of microbial
host immune activation, which occurs at
least in part as a result of coinfecting
microbial infection (Douek, 2003). In this
issue of Cell Host & Microbe, studies by
Lisco and colleagues in the Margolis lab-
oratory at the National Institutes of Health
identify an unexpected type of microbial
interaction that may influence HIV disease
(Lisco et al., 2008), further illustrating the
complex interplay between microbial in-
fections within their hosts.
